Show simple item record

dc.creatorSantoro, Lore
dc.creatorPitalot, Laurine
dc.creatorTrauchessec, Dorian
dc.creatorMora Ramírez, Erick
dc.creatorKotzki, Pierre-Olivier
dc.creatorBardiès, Manuel
dc.creatorDeshayes, Emmanuel
dc.description.abstractThe aim of this study was to compare a commercial dosimetry workstation (PLANET® Dose) and the dosimetry approach (GE Dosimetry Toolkit® and OLINDA/EXM® V1.0) currently used in our department for quantification of the absorbed dose (AD) to organs at risk after peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE.es_ES
dc.rightsCC0 1.0 Universal*
dc.sourceEJNMMI Research. 2021 11, 1es_ES
dc.subjectDosimetry workstationes_ES
dc.subjectPeptide receptor radionuclide therapyes_ES
dc.subject3D calibration factores_ES
dc.subjectVoxel-based dosimetryes_ES
dc.titleClinical implementation of PLANET® Dose for dosimetric assessment after [177Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0es_ES
dc.typeartículo científicoes_ES
dc.description.procedenceUCR::Vicerrectoría de Investigación::Unidades de Investigación::Ciencias Básicas::Centro de Investigación en Ciencias Atómicas Nucleares y Moleculares (CICANUM)es_ES

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

CC0 1.0 Universal
Except where otherwise noted, this item's license is described as CC0 1.0 Universal